First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma Meeting Abstract


Authors: Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; Gerdes, H.; Kelsen, D. P.; Ilson, D. H.; Solit, D.; Schultz, N.; Shah, P. M.; Capanu, M.; Hechtman, J. F.; Lamendola-Essel, M.
Abstract Title: First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma
Meeting Title: 44th ESMO Congress (ESMO 2019)
Journal Title: Annals of Oncology
Volume: 30
Issue: Suppl. 5
Meeting Dates: 2019 Sep 27-Oct 1
Meeting Location: Barcelona, Spain
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2019-10-01
Start Page: mdz247.143
Language: English
ACCESSION: WOS:000491295502244
PROVIDER: wos
DOI: 10.1093/annonc/mdz247.143
Notes: Meeting Abstract: 817P -- Appears on page v313 of the abstract book -- Source: Wos
Altmetric
Citation Impact
MSK Authors
  1. Joanne Fu-Lou Chou
    236 Chou
  2. Hans Gerdes
    159 Gerdes
  3. David Solit
    629 Solit
  4. Geoffrey Yuyat Ku
    151 Ku
  5. Marinela Capanu
    304 Capanu
  6. Yelena Yuriy Janjigian
    244 Janjigian
  7. David H Ilson
    355 Ilson
  8. David P Kelsen
    480 Kelsen
  9. Nikolaus D Schultz
    318 Schultz
  10. Pari Mayank Shah
    31 Shah
  11. Elizabeth Siryeon Won
    34 Won
  12. Jaclyn Frances Hechtman
    196 Hechtman
  13. Parisa   Momtaz
    35 Momtaz
  14. Steven Maron
    27 Maron
  15. Amelia R Gabler
    3 Gabler